Nike to raise costs as Trump’s tariffs on China bite

Nike announced plans to raise prices and significantly reduce its reliance on Chinese production for US imports from 16% to a high single-digit percentage by May 2026, aiming to mitigate an estimated $1 billion in tariff costs. This strategy, coupled with better-than-expected Q4 sales of $11.10 billion and a more favorable Q1 revenue outlook, led to a 15% surge in shares, as the company also saw growth in its running category despite ongoing challenges in the China market and broader industry tariff pressures prompting similar price hikes from competitors.

Analysis

Nike's shares surged 15% following a proactive response to an estimated $1 billion in potential tariff-related costs and a financial performance that surpassed muted expectations. The company plans to mitigate geopolitical risk by significantly reducing its reliance on Chinese manufacturing for the U.S. market, aiming to lower its import share from 16% to a high single-digit percentage by May 2026. This supply chain pivot is coupled with price increases, a move echoed by competitor Adidas, which may preserve Nike's domestic market share. Financially, while fourth-quarter sales fell 12% to $11.10 billion, this result was substantially better than the anticipated 14.9% drop. Similarly, the first-quarter revenue forecast for a mid-single-digit decline is more optimistic than the consensus estimate of a 7.3% fall. Operationally, the company's strategy is showing early signs of success, with the running category returning to growth after a period of weakness, supported by a 15% year-over-year increase in marketing spend. However, management cautions that the China market remains a significant headwind, with a turnaround expected to be slow due to challenging economic conditions.

Key Decisions for Investors

• Investors should recognize management's proactive supply chain diversification as a significant de-risking event that could justify the strong positive market reaction and support a more resilient long-term outlook.
• Monitor the performance of the running category and the success of new product launches, as these are critical indicators of whether the company's innovation and marketing-led strategy can deliver sustained growth.
• Remain cautious regarding the persistent weakness in the China market, as management has explicitly flagged a slow recovery which could act as a drag on overall performance and temper future earnings.